Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer

Roberto Contieri, Alberto Martini, Irene Beijert, Laura S. Mertens, Anouk E. Hentschel, Johannes Bründl, Éva Compérat, Karin Plass, Oscar Rodríguez, José Daniel Subiela, Virginia Hernández, Enrique de la Peña, Isabel Alemany, Diana Turturica, Francesca Pisano, Francesco Soria, Otakar Čapoun, Lenka Bauerová, Michael Pešl, H.M. Bruins, Willemien Runneboom, Sonja Herdegen, Johannes Breyer, A. Brisuda, Ana Calatrava, J. Rubio‐Briones, Maximilian Seles, Sebastian Mannweiler, Judith Bosschieter, V.R.M. Kusuma, David Ashabere, Nicolai Huebner, Thomas Seisen, Francesco Claps, A. Masson-Lecomte, Fredrik Liedberg, Daniel L. Cohen, Luca Lunelli, Olivier Cussenot, Soha El Sheikh, Dimitrios Volanis, Jean‐François Côté, Morgan Rouprêt, Andrea Haitel, Shahrokh F Shariat, Hugh Mostafid, Jakko A. Nieuwenhuijzen, Richard Zigeuner, José L. Domínguez-Escrig, Jaromír Háček, Alexandre R. Zlotta, Maximilian Burger, Matthias Evert, Christina A. Hulsbergen‐van de Kaa, Antoine G. van der Heijden, Lambertus A. Kiemeney, Viktor Soukup, Luca Molinaro, Rodolfo Hurle, Marco Paciotti, Marco Moschini, Benjamin Pradère, Sisto Perdonà, Paolo Gontero, Carlos Llorente, Ferrán Algaba, Joan Palou, James N’Dow, María J. Ribal, Theodorus van der Kwast, Marko Babjuk, Richard Sylvester, Bas W.G. van Rhijn